Joel Jackson

Kent reiterated a conservative balance sheet and a queue of low-risk brownfield growth projects (Wodgina, Talison, Salar, Kings Mountain) but no FIDs kicked off yet.

Masters and Sheorey explained that contract volumes have a 3-month pricing lag. Higher margins in the $20-to-$30 scenario scale linearly, so achieving higher margins requires higher price realization, primarily from the pricing pathway.

Masters acknowledged they are not happy with the safety position and have plans to improve it, but noted safety improvements take time. The mine is operating on plan and CGP3 is ramping on schedule. Declined to comment on the JV partner's motivations.

Masters clarified the $4-5/kg is a general Western vs. China cost differential, not specific to Kemerton. It represents the broad adder for Western operations vs. Chinese conversion.

Masters explained contract volumes have approximately a 2-3 month pricing lag, so Q1 will not fully reflect current spot prices. Spot business gets current pricing but contract volumes lag.

Masters and Norris confirmed ESS demand is real, LFP cell lines at full utilization, global battery partners retrofitting for ESS, and strong uptick from Korean/Japanese cathode producers.

Masters acknowledged the trade-off: disciplined approach risks upside capture but ensures survival through the trough with preserved optionality via world-class resources.

Masters said they're encouraged by government focus on critical minerals and have been discussing public-private partnerships for US lithium supply chain buildout.

Masters confirmed meaningful CGP3 volumes expected early in 2026, not in 2025.

Masters said contracts are holding and performing as expected, with normal ongoing negotiations but no unusual pressure to break floors.

Masters acknowledged supply is harder to predict than demand and confirmed unprofitable operations are proving surprisingly sticky.

Masters explained contracts are adjusted over time rather than expiring and renegotiating, and noted portfolio has become more spot-oriented due to China market growth.

Masters declined to comment on competitor behavior but emphasized Albemarle's focus on bottom-of-cycle competitiveness.

Frost was bullish on the second half, citing the UAN fill program at an average price close to $300 extending into Q4 and a strong fall ammonia season.

Bert explained US well supplied for spring with retail in inventory liquidation mode at historically good average prices. Retailers not taking additional open risk without farmer buyer. Expected Q3 and rest of year to see tighter market with NOLA converging toward world price. North Africa pricing over $800/mt versus US at $600/st highlighting significant global premium.

Chris clarified only the ammonium nitrate plant was damaged. Ammonia, urea liquor, and nitric acid plants unaffected but entire site down due to logistics constraints on moving net ammonia. Late Q4 2026 restart target driven by switchgear and electrical equipment lead times. Rich Hoker noted full year EBITDA impact in $200M range with business interruption insurance expected to offset most or all of the loss.

Chris noted CBAM is currently in effect despite uncertainty. European customers continue showing willingness to pay premium for low-carbon product. Blue Point and Donaldsonville CCS returns were modeled without any product premium, making CBAM benefits purely incremental upside. Low-carbon demand growing beyond Europe into Asia and Africa.

Tony said too early to assess but ammonia plant still operating. Yazoo City is CF's smallest segment and a relatively small plant. Still expecting to produce 10 million tons of gross ammonia for full year. All employees safe with no significant injuries.

Chris said $550M is the better baseline going forward, not $500M. Increase driven by completing more smaller projects, nitric acid precious metals purchase timing, and slightly higher labor and materials inflation of a few percentage points.

Chris corrected the report as inaccurate regarding operational issues. Bert explained the team paused loading briefly to rebuild inventory from just 2,000 tons against 7,500 tons daily production to ensure consistent barge loading rather than sporadic shipments.

Bert described strong Q1 order book exceeding expectations. Low North American inventories and tariff-driven vessel diversions supporting prices into Q2. Fill programs expected to be later than typical due to low inventories.

Joel challenged the CapEx math from Slide 11 versus verbal guidance. Chris and Tony attempted to reconcile but the discussion remained somewhat unclear with Tony acknowledging the numbers move closer to Joel's figure when including scalable infrastructure.

Tony explained modular construction approach with large integrated modules built overseas on fixed-price LSTK basis, dramatically reducing on-site US construction content and inflationary exposure versus historical stick-build approach.

Bert explained the opportunistic hedging approach, hedging front month commitments and weather volatility. Tony reinforced confidence in North American gas positioning.

Tony explained the table uses prior year differentials and product mix, not forward-looking estimates. Chris added that Q1 2024 heavy maintenance skewed the cost structure.

Magro and Johnson said Corteva is comfortable with the ~$4.4B 2027 EBITDA target and trending a little ahead of the original plan.

David outlined modest puts and takes: FX and royalty slightly favorable, Iran conflict adding $40M headwind in H2, tariffs slightly better, tax rate possibly favorable.

David confirmed the Q4-to-Q1 timing shift was in line with original assumptions and did not change the full-year picture.

Chuck said charts should not look the same, corn now starts in 2027 instead of late next decade, plus cotton is new. Agreement does not contemplate wheat, which adds another $1B opportunity. More demand than supply currently exists for licensing.

David said separation management team is running, working to minimize $80-100M dis-synergies. Capital structure details for both companies to come in February. Chuck confirmed $1B buyback commitment for 2025.

David attributed cash flow improvement to earnings increase plus lower cash taxes from new legislation (~4% conversion uplift). Chuck firmly denied any 2026 pull-forward and reiterated 2027 framework tracking.

Chuck said H2 has been derisked since February guide. Q1 was better than expected. H2 CP Brazil needs to match prior year, nothing more. David quantified H1 EBITDA up 4-5% vs originally flat.

David outlined first half up slightly YoY with better second-half comparison. CP pricing pressure more in H1, seed cost improvements more in H2.

Bodine said ammonia rises on inventory flow-through and a mix weighted to contract and internal supply, peaking in Q3 and pressuring stripping margins, plus more idle-cost absorption; margins down but above historic levels.

Bodine differentiated current issues from prior structural asset health problems. Bad days now stem from operational practice, slow startups after repair days, quality issues during product switches (e.g., MAP to MicroEssentials), and inconsistency at high rates. Not structural failures. Requires rebuilding institutional operating knowledge at the front line.

Bodine declined quarterly turnaround cost guidance but offered annualized phosphate turnaround ZIP code of $100-$110M. Noted lumpiness from staggered sulfuric acid, granulation, and phosphoric acid cycles. Potash turnaround differs with Esterhazy pulled from Q3 to Q2 for hydrofloat tie-in. Directed Jackson to Slide 9 for Q-over-Q comparisons.

Wang acknowledged Belarus shipments have not declined as announced but cited offsetting supply reductions from China and Chile SQM. China potash port inventory down 30% YoY to under 2 million tons. In-country producer inventory also down 30%. Low inventory sets up well for China contract negotiations.

Customers waiting for trade deal details and tariff clarity before committing. Positive tailwinds from trade frameworks, tax policy, RVOs, and strong demand fundamentals.